Fund moves

Immix Biopharma (IMMX): Cable Car Capital, LP exited its position 779K shares

Cable Car Capital, LP exited its position in Immix Biopharma, per its Q2 2025 13F.

779K
Prior-quarter shares · no longer reported
Holdings as of
Jun 30, 2025
Filed
Aug 15, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 18, 2025Insider · 2 peopleInsiders: 2 purchases (~$10K)

What came next

  1. Sep 5, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesChanged a top executive or board member, and signed an important agreement (and 1 more item)“Effective September 8, 2025 and in connection with the closing of the Private Placement, the Board of Directors (the “Board”) of the Company appointed Nancy Chang, Ph.D. as a member of the Board.”
  2. Sep 16, 2025InsiderCFO purchased ~$5.1K of IMMX shares in the open market
  3. Sep 17, 2025InsiderCEO purchased ~$5K of IMMX shares in the open market
  4. Dec 7, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Immix Biopharma

OQRO holds no insider, Congress, fund or contract record for Immix Biopharma dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMMX page.

How this filing works

Explore the data

Common questions

What does this filing report about Immix Biopharma (IMMX) stock?

Cable Car Capital, LP exited its position in Immix Biopharma, per its Q2 2025 13F. Held the prior quarter, no longer listed per its Q2 2025 13F.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2025. Filed: Aug 15, 2025.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

Does this mean IMMX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Immix Biopharma

Everything OQRO holds on this company is on its IMMX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data